Drug profile · INN
pitavastatin calcium hydrate
LIVALO
pitavastatin calcium hydrate (LIVALO) is a hmg-coa reductase inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pitavastatin calcium hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
pitavastatin calcium hydrate (LIVALO) is a hmg-coa reductase inhibitor.
Key facts
INN pitavastatin calcium hydrate
Brand LIVALO
Mechanism HMG-CoA reductase inhibitor
Target 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Mechanism of action
HMG-CoA reductase inhibitor
Primary target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pitavastatin calcium hydrate?
pitavastatin calcium hydrate (LIVALO) is a hmg-coa reductase inhibitor.
What is the brand name for pitavastatin calcium hydrate?
LIVALO is a marketed brand name for pitavastatin calcium hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.